Introduction Merck & Co., Inc. is a health care corporation that offers healthcare solutions through its prescription medications, vaccines, biologic therapies, animal health products, and consumer care items. The company operates in three segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical division focuses on human health pharmaceuticals and vaccines, while the Animal Health segment develops, manufactures, and markets animal health products, including pharmaceuticals and vaccines, for livestock and companion animals. The Other segment includes sales from non-reportable healthcare services segments. Established in 1891, Merck & Co., Inc. is headquartered in Kenilworth, New Jersey. |
Disease Domain | Count |
---|---|
Neoplasms | 214 |
Infectious Diseases | 135 |
Endocrinology and Metabolic Disease | 119 |
Immune System Diseases | 110 |
Nervous System Diseases | 98 |
Hemic and Lymphatic Diseases | 79 |
Top 5 Drug Type | Count |
---|---|
Small molecule drug | 247 |
Monoclonal antibody | 48 |
Prophylactic vaccine | 30 |
Chemical drugs | 17 |
Antibody drug conjugate (ADC) | 16 |
Target |
Mechanism TOP1 inhibitors [+1] |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. Japan |
First Approval Date27 Dec 2024 |
Target |
Mechanism TOP1 inhibitors [+1] |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. China |
First Approval Date22 Nov 2024 |
Target- |
Mechanism Immunostimulants |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. United States |
First Approval Date17 Jun 2024 |
Start Date07 Apr 2026 |
Sponsor / Collaborator |
Start Date02 Dec 2025 |
Sponsor / Collaborator |
Start Date07 Sep 2025 |
Sponsor / Collaborator |
Drug(Targets) | Indications | Global Highest Phase |
---|---|---|
Efavirenz ( RT ) | HIV Infections More | Approved |
Ertapenem Sodium ( PBPs ) | Urinary Tract Infections More | Approved |
Daptomycin | Complicated skin and soft tissue infection More | Approved |
Rotavirus vaccine,live(Merck & Co.) | Viral gastroenteritis due to Rotavirus More | Approved |
Ceftolozane Sulfate/Tazobactam Sodium ( PBP1b x PBP3 x β-lactamase ) | Acute pyelonephritis More | Approved |